We also analyzed levels of p62/SQSTM1 in patients with NSCLC who underwent therapeutic pulmonary resection after neoadjuvant chemotherapy, and patients with NSCLC (chemotherapy naïve) who underwent only therapeutic pulmonary resection. Here, SQSTM1 is linked to non-small cell lung carcinoma.